Imunon, Inc. (IMNN) vs Lexaria Bioscience Corp. (LEXX)

Imunon, Inc. and Lexaria Bioscience Corp. are both Biotechnology companies. Imunon, Inc. and Lexaria Bioscience Corp. are of similar size ($7.3M and $7.1M). Lexaria Bioscience Corp. grew revenue faster over the last twelve months: 9.08% against 0.00%. Across the 15 metrics below, Lexaria Bioscience Corp. leads on 12 and Imunon, Inc. on 3.

Valuation

Metric IMNN LEXX Biotechnology median
P/E n/m n/m 7.88
P/S 14.76 10.01 11.47
P/B 3.81 1.25 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 12.10 3.66 10.73
Earnings yield (271.63%) (155.41%) (28.84%)
Free cash flow yield (206.00%) (138.70%) (23.03%)

Profitability

Metric IMNN LEXX Biotechnology median
Gross margin 0.00% 100.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (641.02%) (162.60%) (57.72%)
Return on assets (123.93%) (134.20%) (49.22%)
Return on invested capital (324.37%) (662.56%) 0.00%

Growth

Metric IMNN LEXX Biotechnology median
Revenue growth (TTM) 0.00% 9.08% 5.64%
EPS growth (last fiscal year) 67.66% (40.43%) —
Revenue growth, 5-year CAGR 0.00% 17.53% 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric IMNN LEXX Biotechnology median
Debt to equity 1.32 0.00 0.00
Current ratio 1.82 10.60 4.73
Net debt to EBITDA 0.63 0.17 0.96

Dividend

Metric IMNN LEXX Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric IMNN LEXX Biotechnology median
Market cap 7.30m 7.10m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack